Completed PHASE2 INTERVENTIONAL 3-arm NCT00367380

Evaluation of Reproducibility of a Sporozoite Challenge Model for Plasmodium Vivax in Human Volunteers

Sponsor: Fundacion Clinica Valle del Lili

Conditions ANEMIA Chills FEVER MALARIA Sweating Fever

Updated 10 times since 2017 Last updated: Feb 25, 2021 Started: Dec 31, 2006 Primary completion: Dec 31, 2006 Completion: Mar 31, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates ANEMIA and Chills and is currently completed. Fundacion Clinica Valle del Lili leads this study, which shows 10 recorded versions since 2006 — indicating substantial longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

10 versions recorded

Nov 2025 — Present [monthly]

Completed PHASE2
Sep 2025 — Nov 2025 [monthly]

Completed PHASE2
Sep 2024 — Sep 2025 [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2023 — Jul 2024 [monthly]

Completed PHASE2

▶ Show 5 earlier versions

Dec 2022 — Jan 2023 [monthly]

Completed PHASE2
Apr 2021 — Dec 2022 [monthly]

Completed PHASE2
Jan 2021 — Apr 2021 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Dec 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fundacion Clinica Valle del Lili
Malaria Vaccine and Drug Development Center

Data source: Malaria Vaccine and Drug Development Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Cali, Colombia